US2026043022A1PendingUtilityA1
Method of Modulating Production of Secondary Metabolites
Est. expiryJul 27, 2042(~16 yrs left)· nominal 20-yr term from priority
C12N 15/63C07K 14/36C12R 2001/465C12N 15/1082C12N 15/76
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a method of modulating production of a metabolite in an actinomycetes bacterium comprising increasing the expression or activity of the Sporulation and Antibiotic Production Related gene A (SarA. SCO4069) polypeptide to modulate production of the metabolite in the actinomycetes bacterium. In one embodiment, the metabolite is valinomycin, daidzein, fluvirucin, demethyllydicamycin, or TPU-0037 analogues A. C and D.
Claims
exact text as granted — not AI-modified1 . A method of modulating production of a metabolite in an actinomycetes bacterium, the method comprising increasing the expression or activity of the Sporulation and Antibiotic Production Related gene A (SarA) polypeptide to modulate production of the metabolite in the actinomycetes bacterium.
2 . The method of claim 1 , wherein the method increases or decreases the production of the metabolite in the actinomycetes bacterium.
3 . The method of claim 1 , wherein the metabolite is a secondary metabolite.
4 . The method of claim 1 , wherein the metabolite is valinomycin, daidzein, fluvirucin or demethyllydicamycin.
5 . The method of claim 1 , wherein the metabolite is a compound having the formula of:
wherein R 1 is H or Me and wherein R 2 is H or OH.
6 . The method of claim 1 , wherein the actinomycetes bacterium is a Streptomyces bacterium.
7 . The method of claim 1 , wherein the method comprises genetically modifying the actinomycetes bacterium to have increased expression or activity of the SarA polypeptide.
8 . The method of claim 1 , wherein the method comprises introducing an expression construct comprising a heterologous SarA gene that is operably linked to a promoter to the actinomycetes bacterium.
9 . The method of claim 1 , wherein the method comprises culturing the actinomycetes bacterium so as to modulate the production of the metabolite in the actinomycetes bacterium.
10 . A method of screening for a metabolite produced by an actinomycetes bacterium, the method comprising a) increasing the expression or activity of the Sporulation and Antibiotic Production Related gene A (SarA) polypeptide in an actinomycetes bacterium to modulate production of the metabolite in the actinomycetes bacterium; and b) screening for production of the metabolite in the actinomycetes bacterium.
11 . The method of claim 10 , wherein the method comprises introducing an expression construct comprising a heterologous SarA gene that is operably linked to a promoter.
12 . A method of preparing a drug compound library, the method comprising a) increasing the expression or activity of the Sporulation and Antibiotic Production Related gene A (SarA) polypeptide in an actinomycetes bacterium to modulate production of metabolites in the actinomycetes bacterium; and b) isolating metabolites from the actinomycetes bacterium to prepare the drug compound library.
13 - 15 . (canceled)Join the waitlist — get patent alerts
Track US2026043022A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.